BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32159399)

  • 1. Adult and Cord Blood-Derived High-Affinity gB-CAR-T Cells Effectively React Against Human Cytomegalovirus Infections.
    Olbrich H; Theobald SJ; Slabik C; Gerasch L; Schneider A; Mach M; Shum T; Mamonkin M; Stripecke R
    Hum Gene Ther; 2020 Apr; 31(7-8):423-439. PubMed ID: 32159399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34
    Theobald SJ; Khailaie S; Meyer-Hermann M; Volk V; Olbrich H; Danisch S; Gerasch L; Schneider A; Sinzger C; Schaudien D; Lienenklaus S; Riese P; Guzman CA; Figueiredo C; von Kaisenberg C; Spineli LM; Glaesener S; Meyer-Bahlburg A; Ganser A; Schmitt M; Mach M; Messerle M; Stripecke R
    Front Immunol; 2018; 9():2734. PubMed ID: 30524448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turning the tables on cytomegalovirus: targeting viral Fc receptors by CARs containing mutated CH2-CH3 IgG spacer domains.
    Proff J; Brey CU; Ensser A; Holter W; Lehner M
    J Transl Med; 2018 Feb; 16(1):26. PubMed ID: 29422056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells.
    Drent E; Poels R; Ruiter R; van de Donk NWCJ; Zweegman S; Yuan H; de Bruijn J; Sadelain M; Lokhorst HM; Groen RWJ; Mutis T; Themeli M
    Clin Cancer Res; 2019 Jul; 25(13):4014-4025. PubMed ID: 30979735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation.
    Ludwig B; Kraus FB; Kipp M; Preiser W; Schwerdtfeger R; Doerr HW; Buxbaum S
    J Clin Virol; 2006 Feb; 35(2):160-6. PubMed ID: 16112610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
    Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice.
    Krebs K; Böttinger N; Huang LR; Chmielewski M; Arzberger S; Gasteiger G; Jäger C; Schmitt E; Bohne F; Aichler M; Uckert W; Abken H; Heikenwalder M; Knolle P; Protzer U
    Gastroenterology; 2013 Aug; 145(2):456-65. PubMed ID: 23639914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response.
    Cui X; Cao Z; Wang S; Lee RB; Wang X; Murata H; Adler SP; McVoy MA; Snapper CM
    Vaccine; 2018 Sep; 36(37):5580-5590. PubMed ID: 30082162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gB/CD3 bispecific BiTE antibody construct for targeting Human Cytomegalovirus-infected cells.
    Brey CU; Proff J; Teufert N; Salzer B; Brozy J; Münz M; Pendzialek J; Ensser A; Holter W; Lehner M
    Sci Rep; 2018 Nov; 8(1):17453. PubMed ID: 30487534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of HCMV-specific T-cell lines from seropositive solid-organ-transplant recipients for adoptive T-cell therapy.
    Brestrich G; Zwinger S; Roemhild A; Noutsias M; Rohde M; Keeren K; Sawitzki B; Volk HD; Reinke P; Hammer MH
    J Immunother; 2009; 32(9):932-40. PubMed ID: 19816188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CARs-A New Perspective to HCMV Treatment.
    Bednar C; Ensser A
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7.
    Amatya C; Pegues MA; Lam N; Vanasse D; Geldres C; Choi S; Hewitt SM; Feldman SA; Kochenderfer JN
    Mol Ther; 2021 Feb; 29(2):702-717. PubMed ID: 33129371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes.
    Zhang L; Sosinowski T; Cox AR; Cepeda JR; Sekhar NS; Hartig SM; Miao D; Yu L; Pietropaolo M; Davidson HW
    J Autoimmun; 2019 Jan; 96():50-58. PubMed ID: 30122420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity.
    Song DG; Ye Q; Poussin M; Liu L; Figini M; Powell DJ
    Oncotarget; 2015 Aug; 6(25):21533-46. PubMed ID: 26101914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.
    Gabanti E; Lilleri D; Ripamonti F; Bruno F; Zelini P; Furione M; Colombo AA; Alessandrino EP; Gerna G
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2192-2202. PubMed ID: 26260678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicular helper T-cells and virus-specific antibody response in primary and reactivated human cytomegalovirus infections of the immunocompetent and immunocompromised transplant patients.
    Bruno F; Fornara C; Zelini P; Furione M; Carrara E; Scaramuzzi L; Cane I; Mele F; Sallusto F; Lilleri D; Gerna G
    J Gen Virol; 2016 Aug; 97(8):1928-1941. PubMed ID: 27113912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
    Peggs KS; Mackinnon S
    Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
    Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q
    Front Immunol; 2021; 12():686439. PubMed ID: 34616392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma.
    Zhang C; Wang L; Zhang Q; Shen J; Huang X; Wang M; Huang Y; Chen J; Xu Y; Zhao W; Qi Y; Li Y; Ou Y; Yang Z; Qian C
    Front Immunol; 2023; 14():1182409. PubMed ID: 37304295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rγc-/- mice.
    Salguero G; Sundarasetty BS; Borchers S; Wedekind D; Eiz-Vesper B; Velaga S; Jirmo AC; Behrens G; Warnecke G; Knöfel AK; Blasczyk R; Mischak-Weissinger E; Ganser A; Stripecke R
    Hum Gene Ther; 2011 Oct; 22(10):1209-24. PubMed ID: 21574869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.